FindTrial
Sign In

Study of New Prognostic Factors in Patients Who Received Postoperative Chemotherapy for Endometrial Cancer(JGOG2043-A2)

Study of New Prognostic Factors in Patients Who Received Postoperative Chemotherapy for Endometrial Cancer(JGOG2043-A2) - JGOG2043-A2

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000036755
Enrollment
781
Registered
2019-05-15
Start date
2018-11-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

None listed

Sponsors

Japanese Gynecologic Oncology Group
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The study group comprised 781 patients who were enrolled in the JGOG2043 trial and received chemotherapy.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
We analyzed new prognostic factors in patients who received postoperative chemotherapy for endometrial cancer (patients enrolled in the JGOG2043 study) to investigate an effective classification for clinical practice and new stratification factors for clinical studies.—

Countries

Japan

Contacts

Public ContactShin Nishio

Kurume University School of Medicine Department of Obstetrics and Gynecology

shinshin@med.kurume-u.ac.jp0942-31-7573

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026